DE-IDENTIFIED HEALTH DATA MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• In February 2024, Veradigm, a healthcare technology company, released its inaugural Veradigm Insights Report: Cardiovascular Conditions in 2024, which analyzes de-identified real-world data from 53 million cardiovascular patients. The report explores the prevalence of cardiovascular disease (CVD) and related conditions across U.S. states, including demographic insights by age, ethnicity, and sex.
• In April 2023, Philips, a global health technology company, and MIT's Institute for Medical Engineering and Science (IMES) expanded their collaboration to provide a new, enhanced critical care data set for healthcare researchers. The updated eICU Collaborative Research Database (eICU-CRD) now includes de-identified data from 200,000 critical care patients, including COVID-19 cases, collected from over 200 hospitals. This broader dataset aims to advance machine learning and AI in healthcare by offering detailed clinical data such as vital signs, lab results, diagnoses, and treatment information.
• In July 2021, Verana Health and Komodo Health, healthcare technology companies, partnered to integrate Komodo’s Healthcare Map with Verana’s de-identified EHR datasets, covering over 325 million patient journeys. This partnership offers life sciences researchers detailed patient pathway insights, encompassing treatment histories, hospitalizations, and socioeconomic factors. By merging clinical outcomes with real-world patient data, this partnership aims to advance research in ophthalmology, neurology, and urology to inform treatment development.